Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepatitis C
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepatitis C
    Low-Dose Pegylated Interferon Regimen Shows Sustained Viral Response in Patients With Hepatitis C Genotype 1: Presented at EASL - (DGDispatch)
    TopAbstracts in Hepatitis C 04/29/2008 - (DGNews)
    Taribavirin Comparable in Efficacy to Ribavirin and Results in Less Anaemia in Patients With Chronic Hepatitis C: Presented at EASL - (DGDispatch)
    Nitazoxanide Demonstrates Activity in Treatment-Naive Patients With Hepatitis C Virus Genotype 4: Presented at EASL - (DGDispatch)
    R7128 is Safe, Effective in Short-Term for Patients With Hepatitis C Virus Genotype 1: Presented at EASL - (DGDispatch)

    News archive

     Recent webcasts/CME - Hepatitis C

    Webcasts/CME archive

     Recent cases - Hepatitis C
      Recurrence of Hepatitis C Virus During Leucocytopenia and Spontaneous Clearance after Recovery from Cytopenia: A Case Report
      Successful Outcome of a Pregnancy in Women with Advanced Cirrhosis Due to Hepatitis B Surface Antigenemia, Delta Super-Infection and Hepatitis C Co-Infection: A Case Report
      Extensive Psoriasis Induced by Pegylated Interferon: A Case Report
      Acquired Apolipoprotein B Deficiency with Chronic Hepatitis C Virus Infection
      Hepatitis C Virus-Related Fibrosing Cholestatic Hepatitis in s Renal Transplant Recipient

      Cases archive
        




      my personal edition > hepatitis c > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Hepatitis C Risks Same For Veterans As Civilians

      A DGReview of :"Prevalence and risk factors for hepatitis C virus infection at an Urban Veterans administration medical center (*Human Study*)"
      Hepatology

      12/14/2001
      By Anne MacLennan


      Hepatitis C virus is common in veterans but is more strongly associated with traditional risk factors related to the infection rather than with risks related to combat.

      Intravenous drug use, prior transfusion, prior tattoo, combat medical work, incarceration and multiple opposite sex partners are risk factors independently associated with the infection in this population.

      These are among the findings of a study of hepatitis C virus (HCV) infection at an urban veterans administration medical centre in the United States that sought to determine the seroprevalence and risk factors for this infection in veterans.

      A total of 1,032 veterans participated.

      Researchers performed anti-HCV testing in all of the patients and administered a questionnaire regarding subjects' sociodemographic characteristics and potential risk factors.

      The adjusted prevalence of unique HCV-positive patients using outpatient services was 17.7 percent.

      The range of risk factors found to be linked with HCV infection included a history of injection drug use (IDU), receipt of blood transfusion prior to 1992, history of tattoo, combat job as a medical worker, history of incarceration for more than 48 hours, more than 15 lifetime sexual partners and sexual relations with a prostitute.

      It was concluded that infection with HCV among veterans is common and strongly associated with traditional risk factors and less strongly associated with combat-related risk.

      Megan E. Briggs and colleagues from the Medical Services of the San Francisco Veterans Administration Medical Center, San Francisco, California were the authors of the study.
      HEPATOLOGY 2001;34:1200-1205. "Prevalence and risk factors for hepatitis C virus infection at an Urban Veterans administration medical center (*Human Study*)"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send